Lazard Asset Management’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-38
Closed 2286
2025
Q1
$0 Sell
38
-36
-49% -$537 ﹤0.01% 2290
2024
Q4
$0 Sell
74
-43
-37% -$503 ﹤0.01% 2262
2024
Q3
$1K Sell
117
-93
-44% -$879 ﹤0.01% 2113
2024
Q2
$1K Buy
210
+30
+17% +$196 ﹤0.01% 2123
2024
Q1
$0 Sell
180
-10,119
-98% -$64.8K ﹤0.01% 2024
2023
Q4
$88K Sell
10,299
-407
-4% -$2.98K ﹤0.01% 1706
2023
Q3
$74K Buy
10,706
+1,023
+11% +$6.17K ﹤0.01% 1736
2023
Q2
$55K Buy
+9,683
New +$62.6K ﹤0.01% 1794

Other funds holding ALHC

Lazard Asset Management's ALHC Position: Q2 2025 in Review

Lazard Asset Management sold out of Alignment Healthcare (ALHC) in Q2 2025, closing a stake of 38 shares.

Lazard Asset Management first reported a position in ALHC in Q2 2023 and held it in 8 quarters. The position peaked at $88K in Q4 2023. 217 funds tracked by Wall St. Rank hold ALHC as of Q2 2025.

  • Lazard Asset Management reported no remaining Alignment Healthcare position as of Q2 2025 after selling out during the quarter.
  • Lazard Asset Management sold 38 Alignment Healthcare shares in Q2 2025.
  • Lazard Asset Management first reported a position in Alignment Healthcare in Q2 2023 and held it in 8 quarters.
  • Lazard Asset Management's Alignment Healthcare position peaked at $88K in Q4 2023.
  • 217 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2025.

Based on Lazard Asset Management's 13F filing for Q2 2025, filed 14 Aug 2025.